Launch of US Kidney Care National Plan

Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, welcomes the launch of the Kidney Care National Plan by the US Department of Health and Human Services (“HHS”), a coordinated strategy focused on revitalizing American kidney care.

The 2026 Kidney Care National Plan centres on three priorities:

Prevent Kidney Failure: Detect kidney disease earlier, intervene sooner, and advance treatments and technologies that can slow or stop disease progression.

Improve Dialysis Care and Expand Patient Choice: Promote competition, reduce barriers to entry for new providers and treatments, expand access to home-based care, and support innovations that improve outcomes and quality of life.

Reform Transplantation: Strengthen safety, transparency, and accountability across the transplant system while expanding access to living and deceased-donor transplantation.

Commenting, Sara Barrington, CEO of Verici Dx, said:

“Expanding access to transplantation is essential, but so is making the most of every transplant. For transplant teams, that means having better information to assess rejection risk and inform decisions about patient management.”

“As we work toward a future where more patients can benefit from kidney transplantation, we also need to focus on the tools that can help clinicians make informed decisions throughout the transplant journey. At Verici Dx, we’re addressing this need. Our Tutivia® test classifies kidney transplant recipients as having a low or high risk of acute rejection, giving clinicians additional data-driven information as they manage patients after transplant.”

A Press Release from the US Department of Health and Human Services is available here:

A PDF of the full Kidney Care National Plan is available here: